Ros Matthew 4
4 · Cogent Biosciences, Inc. · Filed Jan 4, 2022
Insider Transaction Report
Form 4
Ros Matthew
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-01-03$5.15/sh+2,256$11,625→ 2,256 totalExercise: $8.70Exp: 2032-01-03→ Common Stock (2,256 underlying)
Footnotes (2)
- [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.
- [F2]This option is fully vested at time of grant.